Gerald Edelman is delighted to announce that its Corporate Finance team has successfully advised on the sale of Medtech company, Edge Medical Limited (“Edge Medical”) to AddLife AB Group (“AddLife”).

Established in 2013 by Mark Vujovich, Edge Medical is a fast-growing, leading distributor of advanced orthopaedic products and services. Built on longstanding, exclusive partnerships with globally renowned manufacturers, the company supplies both public and private hospitals across the UK with a comprehensive portfolio of cutting-edge solutions. Edge Medical has developed a strong reputation for identifying and commercialising innovative technologies, and is active in multiple orthopaedic surgery segments including spine, biologics, pain management, and minimally invasive procedures.

AddLife, a publicly listed company on the Swedish stock exchange, operates across 30 European countries through 86 entrepreneur-led subsidiaries. With annual revenues exceeding 10 billion SEK, AddLife brings significant investment capability and expertise to support Edge Medical’s next phase of growth. The acquisition aligns with AddLife’s strategy to expand in the UK and Irish markets, while strengthening its position in the orthopaedic surgery segment.

Edge Medical will continue to operate independently within AddLife’s group, expanding its already impressive orthopaedic presence into the UK and Ireland. AddLife’s decentralised business model ensures that the entrepreneurial spirit and drive that built the business continues to drive its expansion with a long term owner. Additionally, access to complementary products and services from other AddLife companies will further enhance Edge Medical’s market position.

Mark Vujovich, CEO and Shareholder of Edge Medical, commented:

“We are incredibly excited about the new opportunities, experience and investment that AddLife brings to Edge Medical. AddLife are an experienced specialist provider to the Life Science market segment and offer a long-term perspective, a European presence and a complimentary portfolio of supplier and proprietary brands, which will ultimately enhance our offering to our customers.

The Gerald Edelman team provided outstanding support throughout the process. They ran an efficient and competitive process, introducing us to a diverse range of potential partners from various geographies. Ultimately, AddLife was the right choice, and I look forward to leading Edge Medical into its next successful chapter under their ownership.”

Sam Barr, Director at Gerald Edelman, added:

“This transaction marks a significant milestone for Edge Medical, and we are thrilled to have helped secure such a successful outcome for Mark and the company. Our goal was to find the ideal home – one that could not only accelerate the company’s impressive growth but also align with its strong culture and values. The strong interest we received is a testament to Edge Medical’s expertise in identifying and commercialising innovative products. From our first meeting, it was clear that AddLife was the perfect fit, and we look forward to seeing Edge Medical thrive under its ownership. We wish both teams continued success.”

Warren Meggitt, Associate Partner at Gerald Edelman, added:

“As soon as we met with Mark, we knew what an incredible proposition this market-leading distributor of specialty orthopaedic products could be to the market incumbents. We are delighted for Edge Medical to have found a prosperous new home with AddLife, and once integrated into their infrastructure, we are sure that both businesses will exponentially flourish… Well done to everyone involved!”

Edge Medical was also advised by Fladgate (legal).

Stay ahead with the newest legal updates at GLE News